Northern RNA Attending the LNP Formulation & PD Summit in Boston
Proud to be partnering and sponsoring the LNP Formulation & Process Development Summit in Boston. Apr 14-16. Interact with Diana or John at our booth. Read more at https://www.linkedin.com/posts/northernrna_lnp-rna-plasmid-activity
Dr. John Ballantyne, PhD, successful biotechnology executive and founder joins Northern RNA Board of Directors
Posted on 27 March 2025 by Northern RNA CALGARY, CANADA – 27 March 2025 – Northern RNA, a leading contract drug manufacturing organization (CDMO) specializing in GMP manufacturing of RNA-based vaccines and therapeutics, today announced the appointment of Dr. John Ballantyne, PhD, to its Board of Directors “We are pleased to welcome John Ballantyne […]
Northern RNA Inc. awarded grant funding from Alberta Innovates to support the development of next generation lipids
Posted on March 10, 2025 by Northern RNA CALGARY, Alberta (March 10, 2025) – Northern RNA today announced that they have been awarded grant funding from Alberta Innovates to support the development of advanced manufacturing processes for next generation lipids. The next generation lipid manufacturing effort addresses a critical gap in the global supply of […]
Northern RNA and Epitopea Announce Strategic Collaboration Agreement
Northern RNA and Epitopea Announce Strategic Collaboration Agreement Posted on 24 February 2025 by Northern RNA CALGARY, CANADA and MONTREAL CANADA – February 24, 2025 – Northern RNA, a contract drug manufacturing organization (CDMO) specializing in GMP manufacturing of RNA-based vaccines and therapeutics, and Epitopea, a transatlantic cancer immunotherapeutics company developing accessible off-the-shelf RNA-based immunotherapies, today announced they have entered […]
Northern RNA Inc. has been recognized by BioTalent Canada as an I.D.E.A.L. Bioscience Employer for 2024-2025
Calgary, February 06, 2025 – Northern RNA Inc. has been recognized by BioTalent Canada as an I.D.E.A.L. Bioscience Employer™ for 2024-2025. This recognition highlights the efforts of Northern RNA in implementing IDEA best practices into their workplace while shaping a stronger Canadian bio-economy. “We are honoured to be recognized as a 2024-2025 I.D.E.A.L. Bioscience Employer,” […]
Northern RNA Inc. Signs Memorandum of Understanding with Alexander Chemical L.P.
Northern RNA Inc. Signs Memorandum of Understanding with Alexander Chemical L.P. Posted on February 03, 2025 by Northern RNA CALGARY, Alberta February 3, 2025 – Northern RNA Inc. is excited to announce that we have signed a Memorandum of Understanding (MOU) with Alexander Chemical L.P. (ACLP), a majority First Nations owned and Canadian owned company. […]
Northern RNA and Kaster Technologies announce Memorandum of Understanding
Calgary, Alberta October 28, 2024 – Northern RNA Inc. is excited to announce the signing of a Memorandum of Understanding (MOU) with Kaster Technologies Inc., a cutting-edge Canadian company specializing in digital tools for optimizing drug and life science manufacturing. This MOU marks an exciting milestone for Northern RNA as we seek to strengthen our […]